참고문헌
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33. https://doi.org/10.3322/caac.21708
- Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022;399:1607-17. https://doi.org/10.1016/S0140-6736(21)02333-3
- Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2013;146:372-8. https://doi.org/10.1016/j.jtcvs.2013.02.057
- Jiang L, Liang W, Shen J, et al. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis. Chest 2015;148:903-11. https://doi.org/10.1378/chest.14-2765
- Rami-Porta R, Bolejack V, Giroux DJ, et al. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2014;9:1618-24. https://doi.org/10.1097/JTO.0000000000000334
- Travis WD, Brambilla E, Rami-Porta R, et al. Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 2008;3:1384-90. https://doi.org/10.1097/JTO.0b013e31818e0d9f
- Kim H, Goo JM, Kim YT, Park CM. CT-defined visceral pleural invasion in T1 lung adenocarcinoma: lack of relationship to disease-free survival. Radiology 2019;292:741-9. https://doi.org/10.1148/radiol.2019190297
- Shi J, Li F, Yang F, et al. The combination of computed tomography features and circulating tumor cells increases the surgical prediction of visceral pleural invasion in clinical T1N0M0 lung adenocarcinoma. Transl Lung Cancer Res 2021;10:4266-80. https://doi.org/10.21037/tlcr-21-896
- Yang S, Yang L, Teng L, et al. Visceral pleural invasion by pulmonary adenocarcinoma ≤3 cm: the pathological correlation with pleural signs on computed tomography. J Thorac Dis 2018;10:3992-9. https://doi.org/10.21037/jtd.2018.06.125
- Hsu JS, Han IT, Tsai TH, et al. Pleural tags on CT scans to predict visceral pleural invasion of non-small cell lung cancer that does not abut the pleura. Radiology 2016;279:590-6. https://doi.org/10.1148/radiol.2015151120
- Riquet M, Badoual C, Le Pimpec Barthes F, et al. Visceral pleura invasion and pleural lavage tumor cytology by lung cancer: a prospective appraisal. Ann Thorac Surg 2003;75:353-5. https://doi.org/10.1016/s0003-4975(02)04403-x
- Iizuka S, Kawase A, Oiwa H, Ema T, Shiiya N, Funai K. A risk scoring system for predicting visceral pleural invasion in non-small lung cancer patients. Gen Thorac Cardiovasc Surg 2019;67:876-9. https://doi.org/10.1007/s11748-019-01101-x
- Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;130:160-5. https://doi.org/10.1016/j.jtcvs.2004.11.021
- Tanaka T, Shinya T, Sato S, et al. Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact. Ann Nucl Med 2015;29:757-65. https://doi.org/10.1007/s12149-015-0999-x
- National Comprehensive Cancer Network. Non-small cell lung cancer [Internet]. National Comprehensive Cancer Network; 2023 [cited 2023 Sep 24]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf
- Chen Z, Jiang S, Li Z, Rao L, Zhang X. Clinical value of 18F-FDG PET/CT in prediction of visceral pleural invasion of subsolid nodule stage I lung adenocarcinoma. Acad Radiol 2020;27:1691-9. https://doi.org/10.1016/j.acra.2020.01.019
- Zhang A, Meng X, Yao Y, et al. Predictive value of 18 F-FDG PET/MRI for pleural invasion in solid and subsolid lung adenocarcinomas smaller than 3 cm. J Magn Reson Imaging 2023;57:1367-75. https://doi.org/10.1002/jmri.28422
- Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in ung cancer. Lung Cancer. 2012;76:138-43. https://doi.org/10.1016/j.lungcan.2011.11.012
- Feng M, Zhu J, Liang L, et al Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis. Int J Clin Oncol 2017;22:283-90. https://doi.org/10.1007/s10147-016-1073-y
- Nguyen AH, Miller EJ, Wichman CS, Berim IG, Agrawal DK. Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis. Transl Res 2015;166:432-9. https://doi.org/10.1016/j.trsl.2015.04.006
- Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Chest 2005;128:2298-303. https://doi.org/10.1378/chest.128.4.2298
- Hsieh TC, Huang WW, Lai CL, Tsao SM, Su CC. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions. Cancer Cytopathol 2013;121:483-8. https://doi.org/10.1002/cncy.21283
- Satoh Y, Sugai S, Uehara H, et al. Clinical impact of intraoperative detection of carcinoembryonic antigen mRNA in pleural lavage specimens from nonsmall cell lung cancer patients. Thorac Cardiovasc Surg 2012;60:533-40. https://doi.org/10.1055/s-0031-1298066